Molecular Monitoring in Endometrial Cancer-Ready for Prime Time?

被引：4
|
作者：
Grant, Brooke M. [1 ]
Pugh, Trevor J. [1 ,2 ,3 ]
Oza, Amit M. [1 ,4 ,5 ]
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Ontario Inst Canc Res, Toronto, ON, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, 610 Univ Ave, Toronto, ON M5G 2M9, Canada
来源：
CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 02期
关键词：
D O I：
10.1158/1078-0432.CCR-22-2781
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Efforts are under way to define the role of minimally invasive strategies for molecular monitoring and risk stratification in endo-metrial cancer. A recent publication aims to define the association between circulating tumor DNA level and disease stage in patients with newly diagnosed endometrial cancer and determine whether sequencing of longitudinal cell-free DNA samples can be used for disease monitoring and detection of progression or recurrence. These results accelerate the current knowledge of molecular fol-low-up in endometrial cancer.
引用
收藏
页码：305 / 308
页数：4
相关论文
共 50 条
  • [1] Deciphering Genomic Risk in Prostate Cancer-Ready for Prime Time
    McGuire, Sean E.
    JAMA ONCOLOGY, 2021, 7 (04) : 553 - 554
  • [2] Online tools for patient counseling in bladder and kidney cancer-ready for prime time?
    Gild, Philipp
    Rink, Michael
    Meyer, Christian P.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2017, 6 (06) : 1123 - 1131
  • [3] Immunotherapy in Head and Neck Cancer-Ready for Prime Time or More Research Needed?
    Karam, Sana D.
    Anderson, Carryn M.
    Ma, Daniel
    Chua, Melvin L. K.
    Kimple, Randall J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (03): : 647 - 650
  • [4] Multi-Modality Therapy for Metastatic Colorectal Cancer-Ready for Prime Time?
    Chua, Terence C.
    Marshall, John L.
    Marshall, M. Blair
    Esquivel, Jesus
    AMERICAN SURGEON, 2010, 76 (07) : 777 - 778
  • [5] ctDNA-guided adjuvant chemotherapy for colorectal cancer-ready for prime time?
    Andersen, Claus L.
    Heitzer, Ellen
    CANCER CELL, 2022, 40 (09) : 911 - 913
  • [6] Carboplatin in the neoadjuvant treatment of triple-negative breast cancer-ready for prime time?
    Foukakis, T.
    ANNALS OF ONCOLOGY, 2018, 29 (12) : 2278 - 2280
  • [7] Letter: faecal immunochemical testing for adults with symptoms of colorectal cancer-ready for prime time?
    Farrugia, Alexia
    Widlak, Monika M.
    Smith, Stephen
    Waugh, Norman
    Arasaradnam, Ramesh P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1419 - 1419
  • [8] Alternatives to Surgery for Early Stage Non-Small Cell Lung Cancer-Ready for Prime Time?
    Das, Millie
    Abdelmaksoud, Mohamed H. K.
    Loo, Billy W., Jr.
    Kothary, Nishita
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2010, 11 (1-2) : 24 - 35
  • [9] Molecular profiling in breast cancer-ready for clinical routine?
    Tendl, Kristina A.
    Bago-Horvath, Zsuzsanna
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (04) : 445 - 449
  • [10] Alternatives to Surgery for Early Stage Non-Small Cell Lung Cancer-Ready for Prime Time?
    Millie Das
    Mohamed H. K. Abdelmaksoud
    Billy W. Loo
    Nishita Kothary
    Current Treatment Options in Oncology, 2010, 11 : 24 - 35
12345